...
首页> 外文期刊>Drug and Chemical Toxicology >A Notable Antimutagenicity of Two Nonmutagenic Novel Oxadiazoles in Salmonella Mutagenicity Assay
【24h】

A Notable Antimutagenicity of Two Nonmutagenic Novel Oxadiazoles in Salmonella Mutagenicity Assay

机译:沙门氏菌致突变性检测中的两个非致突变性新型恶二唑的显着抗突变性。

获取原文
获取原文并翻译 | 示例
           

摘要

The mutagenic activity of two newly synthesized oxadiazoles:l,3-bis(5-benzylthio-l,3,4-oxadiazol-2-yl)benzene (Ml)and l,4-bis(5-benzylthio-l,3,4-oxadiazol-2-yl)benzene (M2)was studied in Salmonella typhimurium strains TA97,TA100,TA102 and TA1537 in the presence and absence of S9mix.The antimutagenicity of M1 and M2 against H_2O_2,sodium azide (SA)and 4-nitro-o-phenylene diamine (NPD)using the tester strains TA102,TA100 and TA97,respectively,was also investigated.The two compounds were found to be nonmutagenic using the four tester strains.However,they showed high mutagenic repression activity against hydrogen peroxide (95% and 97% for Ml and M2,respectively,at a concentration of 335 mug/plate).Moderate mutagenic repression against NPD (58% and 55% for Ml and M2,respectively,at a concentration of 167.5 mug/plate)and low mutagenic repression against SA (21% and 33% for Ml and M2 respectively,at a concentration of 335 mug/plate)was detected.The obtained results are very encouraging to test the above mentioned compounds as anticarcinogens.
机译:两种新合成的恶二唑的诱变活性:1,3-双(5-苄硫基-1,3,4-恶二唑-2-基)苯(M1)和1,4-双(5-苄硫基-1,3,在有和没有S9mix的情况下,在鼠伤寒沙门氏菌TA97,TA100,TA102和TA1537菌株中研究了4-恶二唑-2-基)苯(M2).M1和M2对H_2O_2,叠氮化钠(SA)和4-的抗突变性还分别使用测试菌株TA102,TA100和TA97对硝基邻苯二胺(NPD)进行了研究。使用这四个测试菌株发现这两种化合物是非致突变性的,但是它们对过氧化氢具有很高的诱变抑制活性(M1和M2分别在335杯/板的浓度下分别为95%和97%)。对NPD的中等致突变抑制(M1和M2在167.5杯子/板的浓度下分别为58%和55%)并检测到对SA的低致突变性抑制(M1和M2浓度分别为335杯/平板时分别为M1和M2的21%和33%)。上述化合物为抗癌剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号